The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a exciting breakthrough. Unlike injections, this method offers a less invasive way to administer GLP-1 medications. These transdermal systems slowly release the treatment through the skin offering a even level of the active agent, which can im… Read More